Table 3.
Univariate analysis of predictive factors of post-operative exocrine insufficiency
| Variables | Presence of new post-operative exocrine insufficiency (n = 94)a | Absence of new post-operative exocrine insufficiency (n = 120)a | p-value |
|---|---|---|---|
| Gender, N (%) | |||
| Female | 40 (43) | 71 (59) | 0.014 |
| Male | 54 (57) | 49 (41) | |
| Body mass index (kg/m2) | 27.9 ± 7.0 | 28.3 ± 6.9 | 0.745 |
| Pancreaticoduodenectomy, N (%) | 80 (85) | 71 (60) | <0.001 |
| Malignant pathology, N (%) | 72 (83) | 61 (62) | 0.002 |
| Partial gastrectomy, N (%) | 50 (56) | 38 (33) | 0.001 |
| Location, tail, N (%) | 7 (8) | 20 (18) | 0.036 |
| Pathologic presence of pancreatitis, N (%) | 24 (27) | 28 (25) | 0.724 |
| Neoadjuvant chemotherapy, N (%) | 9 (10) | 4 (3) | 0.050 |
| Adjuvant chemotherapy, N (%) | 62 (69) | 40 (35) | <0.001 |
| Neoadjuvant radiation therapy, N (%) | 8 (9) | 5 (4) | 0.175 |
| Adjuvant radiation therapy, N (%) | 48 (53) | 29 (26) | <0.001 |
a
Due to missing data points, percentages are based upon n of available data points.